Frost & Sullivan Research Service   Published: 14 Nov 2016
Analysis of the Indonesian Clinical Laboratories Market
  SERVICE HOMEPAGE
FURTHER INFORMATION
  Table Of Contents
  1 | ANALYSIS OF THE INDONESIAN CLINICAL LABORATORIES MARKET
   Executive Summary
      1. Methodology
      2. Key Findings
      3. Key Findings (continued)
      4. Key Trends
      5. Key Questions this Study will Answer
      6. Executive Summary—Market Engineering Measurements
      7. Key Companies to Watch
      8. 3 Big Predictions

  Market Overview
      1. Market Overview
      2. Market Overview (continued)
      3. Market Segmentation
      4. Indonesia—Independent Laboratory Classification
      5. Market Segmentation
      6. Top Trends in Indonesia’s Clinical Laboratory Market
      7. Defining Future Trends in Healthcare
      8. Current Lab Operations Outsourcing—Examples
      9. Current Lab Infrastructure Outsourcing—Examples
      10. Private Independent Lab Collaboration with BPJS*

  Competitive Playbook
      1. Competitive Structure
      2. Indonesian Independent Labs—Market Share by Key Players
      3. Clinical Laboratory Market Access in Indonesia—Game-changing Strategies
      4. Merger, Acquisition, and Partnership Assessment

  External Challenges—Drivers and Restraints: Total Clinical Laboratory Market
      1. Market Drivers
      2. Drivers Explained
      3. Drivers Explained (continued)
      4. Drivers Explained (continued)
      5. Drivers Explained (continued)
      6. Market Restraints
      7. Restraints Explained
      8. Restraints Explained (continued)
      9. Impact Mapping of Drivers and Restraints

  Forecasts and Trends—Total Clinical Laboratory Market
      1. Forecast Assumptions
      2. Measurements
      3. Revenue Forecast by Segment
      4. Volume Forecast by Segment
      5. Revenue and Volume Forecast Discussion

  Key Company Profiles
      1. Company Information—Prodia
      2. Company Information—Kimia Farma
      3. Company Information—Lab Cito
      4. Company Information—Pramita
      5. Company Information—Parahita

  Regulatory Review and Outlook
      1. Healthcare Investment Regulations—The Negative Investment List for Laboratory Clinics
      2. License/Permit Application
      3. Regulations for Setting Up Laboratory Clinics According to PMK 411/2010
      4. Regulations on Transport of Tests and Quality Control Management
      5. Material Transfer Agreement (MTA) is Outlined in PMK 657/2010
      6. Standalone Collection Centres are Not Permitted in Indonesia
      7. Collection Centres—Outline of Room and Support Facilities Requirements Based on MOH Regulation 43/2013
      8. Clinical Laboratory Human Resource Requirements
      9. Clinical Laboratory Human Resource Requirements (continued)

  The Last Word
      1. The Last Word—3 Big Predictions
      2. Legal Disclaimer

  Appendix
      1. Total Healthcare Expenditure
      2. Total Healthcare Expenditure (continued)
      3. Public Healthcare Expenditure
      4. Public Healthcare Expenditure (continued)
      5. Private Healthcare Expenditure
      6. Private Healthcare Expenditure (continued)
      7. Number of Hospital Beds
      8. Number of Hospital Beds (continued)
      9. Number of Hospitals
      10. Number of Hospitals (continued)

Conseq